The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbCellera Biologics Inc. | COM | 00288U106 | 229,904 | 10,450,180 | SH | SOLE | 10,450,180 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,022,202 | 41,910,704 | SH | SOLE | 41,910,704 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 2,815 | 22,430 | SH | SOLE | 22,430 | 0 | 0 | ||
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 25,369 | 2,591,366 | SH | SOLE | 2,591,366 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 41,880 | 9,830,877 | SH | SOLE | 9,830,877 | 0 | 0 | ||
ADC Therapeutics SA | SHS | H0036K147 | 34,531 | 1,418,107 | SH | SOLE | 1,418,107 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 23,734 | 3,410,106 | SH | SOLE | 3,410,106 | 0 | 0 | ||
Aerovate Therapeutics, Inc. | COM | 008064107 | 32,614 | 1,428,571 | SH | SOLE | 1,428,571 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 1,399 | 164,605 | SH | SOLE | 164,605 | 0 | 0 | ||
Akero Therapeutics, Inc. | COM | 00973Y108 | 2,937 | 118,378 | SH | SOLE | 118,378 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 14,511 | 412,466 | SH | SOLE | 412,466 | 0 | 0 | ||
Alector, Inc. | COM | 014442107 | 4,983 | 239,228 | SH | SOLE | 239,228 | 0 | 0 | ||
Aligos Therapeutics, Inc. | COM | 01626L105 | 32,820 | 1,610,000 | SH | SOLE | 1,610,000 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 30,115 | 1,228,170 | SH | SOLE | 1,228,170 | 0 | 0 | ||
Allakos Inc. | COM | 01671P100 | 60,019 | 703,050 | SH | SOLE | 703,050 | 0 | 0 | ||
Altimmune, Inc. | COM | 02155H200 | 10,560 | 1,072,038 | SH | SOLE | 1,072,038 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR | 023111206 | 115,866 | 26,453,422 | SH | SOLE | 26,453,422 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 11,077 | 427,179 | SH | SOLE | 427,179 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 143,585 | 2,271,917 | SH | SOLE | 2,271,917 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 337,065 | 1,119,557 | SH | SOLE | 1,119,557 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 465,723 | 3,540,270 | SH | SOLE | 3,540,270 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 8,181 | 2,108,621 | SH | SOLE | 2,108,621 | 0 | 0 | ||
Athira Pharma, Inc. | COM | 04746L104 | 8,257 | 806,367 | SH | SOLE | 806,367 | 0 | 0 | ||
Atreca, Inc. | CL A COM | 04965G109 | 30,099 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 14,515 | 1,119,962 | SH | SOLE | 1,119,962 | 0 | 0 | ||
Axsome Therapeutics, Inc. | COM | 05464T104 | 36,365 | 539,057 | SH | SOLE | 539,057 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 4,004,649 | 11,668,897 | SH | SOLE | 11,668,897 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 822 | 249,123 | SH | SOLE | 249,123 | 0 | 0 | ||
BioAtla, Inc. | COM | 09077B104 | 34,964 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 200,958 | 12,710,818 | SH | SOLE | 12,710,818 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 633,251 | 7,589,294 | SH | SOLE | 7,589,294 | 0 | 0 | ||
Biomea Fusion, Inc. | COM | 09077A106 | 4,591 | 294,117 | SH | SOLE | 294,117 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 7,259 | 226,988 | SH | SOLE | 226,988 | 0 | 0 | ||
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 6,161 | 209,131 | SH | SOLE | 209,131 | 0 | 0 | ||
Cabaletta Bio, Inc. | COM | 12674W109 | 5,473 | 636,363 | SH | SOLE | 636,363 | 0 | 0 | ||
Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 8,884 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 81,045 | 13,713,195 | SH | SOLE | 13,713,195 | 0 | 0 | ||
Chiasma, Inc. | COM | 16706W102 | 6,720 | 1,420,740 | SH | SOLE | 1,420,740 | 0 | 0 | ||
Chinook Therapeutics, Inc. | COM | 16961L106 | 15,255 | 1,080,393 | SH | SOLE | 1,080,393 | 0 | 0 | ||
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 17,354 | 920,656 | SH | SOLE | 920,656 | 0 | 0 | ||
Cymabay Therapeutics, Inc. | COM | 23257D103 | 9,463 | 2,170,464 | SH | SOLE | 2,170,464 | 0 | 0 | ||
Cyteir Therapeutics, Inc. | COM | 23284P103 | 17,390 | 812,640 | SH | SOLE | 812,640 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 79,794 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | ||
Denali Therapeutics Inc. | COM | 24823R105 | 6,961 | 88,738 | SH | SOLE | 88,738 | 0 | 0 | ||
Design Therapeutics, Inc. | COM | 25056L103 | 28,575 | 1,436,636 | SH | SOLE | 1,436,636 | 0 | 0 | ||
Edgewise Therapeutics, Inc. | COM | 28036F105 | 10,665 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Evofem Biosciences, Inc. | COM | 30048L104 | 3,048 | 2,697,110 | SH | SOLE | 2,697,110 | 0 | 0 | ||
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 50,399 | 2,024,876 | SH | SOLE | 2,024,876 | 0 | 0 | ||
Frequency Therapeutics, Inc. | COM | 35803L108 | 553 | 55,555 | SH | SOLE | 55,555 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 36,986 | 401,016 | SH | SOLE | 401,016 | 0 | 0 | ||
Gamida Cell Ltd. | SHS | M47364100 | 3,914 | 610,626 | SH | SOLE | 610,626 | 0 | 0 | ||
Genetron Holdings Limited | ADS | 37186H100 | 9,170 | 455,306 | SH | SOLE | 455,306 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | COM | 37890U108 | 112,675 | 3,217,441 | SH | SOLE | 3,217,441 | 0 | 0 | ||
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 3,489 | 123,600 | SH | SOLE | 123,600 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 126,204 | 8,131,678 | SH | SOLE | 8,131,678 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 6,416 | 700,481 | SH | SOLE | 700,481 | 0 | 0 | ||
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 56,101 | 599,110 | SH | SOLE | 599,110 | 0 | 0 | ||
IGM Biosciences, Inc. | COM | 449585108 | 262,588 | 3,156,102 | SH | SOLE | 3,156,102 | 0 | 0 | ||
Immatics N.V. | SHS | N44445109 | 49,725 | 4,282,938 | SH | SOLE | 4,282,938 | 0 | 0 | ||
Immunocore Holdings plc | ADS | 45258D105 | 98,435 | 2,520,730 | SH | SOLE | 2,520,730 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,693,988 | 32,021,732 | SH | SOLE | 32,021,732 | 0 | 0 | ||
Inozyme Pharma, Inc. | COM | 45790W108 | 1,823 | 106,999 | SH | SOLE | 106,999 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 61,360 | 2,156,001 | SH | SOLE | 2,156,001 | 0 | 0 | ||
Instil Bio, Inc. | COM | 45783C101 | 75,226 | 3,893,700 | SH | SOLE | 3,893,700 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 345,684 | 10,248,575 | SH | SOLE | 10,248,575 | 0 | 0 | ||
Iteos Therapeutics, Inc. | COM | 46565G104 | 3,856 | 150,346 | SH | SOLE | 150,346 | 0 | 0 | ||
IVERIC bio, Inc. | COM | 46583P102 | 8,872 | 1,406,037 | SH | SOLE | 1,406,037 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COM | 48576A100 | 7,975 | 69,966 | SH | SOLE | 69,966 | 0 | 0 | ||
Kezar Life Sciences, Inc. | COM | 49372L100 | 758 | 139,676 | SH | SOLE | 139,676 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 38,998 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | ||
Kodiak Sciences Inc. | COM | 50015M109 | 1,314,823 | 14,137,881 | SH | SOLE | 14,137,881 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 41,326 | 607,735 | SH | SOLE | 607,735 | 0 | 0 | ||
Kymera Therapeutics, Inc. | COM | 501575104 | 95,022 | 1,959,211 | SH | SOLE | 1,959,211 | 0 | 0 | ||
Leap Therapeutics, Inc. | COM | 52187K101 | 918 | 559,705 | SH | SOLE | 559,705 | 0 | 0 | ||
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 68,329 | 1,664,534 | SH | SOLE | 1,664,534 | 0 | 0 | ||
LogicBio Therapeutics, Inc. | COM | 54142F102 | 2,005 | 451,478 | SH | SOLE | 451,478 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 5,390 | 200,679 | SH | SOLE | 200,679 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 146,038 | 1,499,213 | SH | SOLE | 1,499,213 | 0 | 0 | ||
Mereo BioPharma Group plc | ADS | 589492107 | 7,796 | 2,459,399 | SH | SOLE | 2,459,399 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 42,929 | 2,037,469 | SH | SOLE | 2,037,469 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 227,722 | 1,409,784 | SH | SOLE | 1,409,784 | 0 | 0 | ||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 11,192 | 647,313 | SH | SOLE | 647,313 | 0 | 0 | ||
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 35,275 | 3,821,740 | SH | SOLE | 3,821,740 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 65,883 | 676,975 | SH | SOLE | 676,975 | 0 | 0 | ||
NexImmune, Inc. | COM | 65344D109 | 4,800 | 294,117 | SH | SOLE | 294,117 | 0 | 0 | ||
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 5,754 | 291,801 | SH | SOLE | 291,801 | 0 | 0 | ||
Novavax, Inc. | COM | 670002401 | 30,521 | 143,756 | SH | SOLE | 143,756 | 0 | 0 | ||
Nurix Therapeutics, Inc. | COM | 67080M103 | 65,107 | 2,454,082 | SH | SOLE | 2,454,082 | 0 | 0 | ||
Opthea Limited | SPONSORED ADS | 68386J208 | 27,092 | 3,412,062 | SH | SOLE | 3,412,062 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 5,233 | 1,192,003 | SH | SOLE | 1,192,003 | 0 | 0 | ||
Otonomy, Inc. | COM | 68906L105 | 16,106 | 7,222,474 | SH | SOLE | 7,222,474 | 0 | 0 | ||
Oyster Point Pharma, Inc. | COM | 69242L106 | 1,056 | 61,424 | SH | SOLE | 61,424 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 111,973 | 3,201,972 | SH | SOLE | 3,201,972 | 0 | 0 | ||
Passage Bio, Inc. | COM | 702712100 | 1,551 | 117,161 | SH | SOLE | 117,161 | 0 | 0 | ||
Prelude Therapeutics Incorporated | COM | 74065P101 | 289,845 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | ||
Protagonist Therapeutics, Inc. | COM | 74366E102 | 20,433 | 455,276 | SH | SOLE | 455,276 | 0 | 0 | ||
Protara Therapeutics, Inc. | COM STK | 74365U107 | 1,945 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | ||
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 31,699 | 223,976 | SH | SOLE | 223,976 | 0 | 0 | ||
Relmada Therapeutics, Inc. | COM | 75955J402 | 2,452 | 76,600 | SH | SOLE | 76,600 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 5,898 | 153,512 | SH | SOLE | 153,512 | 0 | 0 | ||
Revolution Medicines, Inc. | COM | 76155X100 | 7,053 | 222,222 | SH | SOLE | 222,222 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 75,642 | 3,863,239 | SH | SOLE | 3,863,239 | 0 | 0 | ||
Seagen Inc. | COM | 81181C104 | 7,465,870 | 47,288,259 | SH | SOLE | 47,288,259 | 0 | 0 | ||
Silverback Therapeutics, Inc. | COM | 82835W108 | 7,355 | 238,095 | SH | SOLE | 238,095 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 357 | 65,497 | SH | SOLE | 65,497 | 0 | 0 | ||
Talis Biomedical Corporation | COM | 87424L108 | 83,550 | 7,574,835 | SH | SOLE | 7,574,835 | 0 | 0 | ||
TCR2 Therapeutics Inc. | COM | 87808K106 | 2,896 | 176,461 | SH | SOLE | 176,461 | 0 | 0 | ||
Travere Therapeutics, Inc. | COM | 89422G107 | 2,727 | 186,915 | SH | SOLE | 186,915 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 3,151 | 729,300 | SH | SOLE | 729,300 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 42,378 | 444,444 | SH | SOLE | 444,444 | 0 | 0 | ||
Verastem, Inc. | COM | 92337C104 | 87,471 | 21,491,630 | SH | SOLE | 21,491,630 | 0 | 0 | ||
Verve Therapeutics, Inc. | COM | 92539P101 | 85,346 | 1,416,530 | SH | SOLE | 1,416,530 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 13,996 | 751,639 | SH | SOLE | 751,639 | 0 | 0 | ||
Zymeworks Inc. | COM | 98985W102 | 59,267 | 1,708,472 | SH | SOLE | 1,708,472 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Note 3.5% 9/15/2026 | 03753UAB2 | 27,793 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Note 0.599% 8/1/2024 | 09061GAH4 | 15,566 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | 44,063 | 40,000,000 | PRN | SOLE | 40,000,000 | 0 | 0 | ||
Invitae Corporation | Note 2.0% 9/1/2024 | 46185LAB9 | 13,890 | 10,300,000 | PRN | SOLE | 10,300,000 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | 38,479 | 29,174,000 | PRN | SOLE | 29,174,000 | 0 | 0 | ||
Tricida, Inc. | Note 3.5% 5/15/2027 | 89610FAB7 | 27,332 | 75,000,000 | PRN | SOLE | 75,000,000 | 0 | 0 |